View: Will Trump's tariffs lift the veil on India's drug safety problem?

India’s pharmaceutical industry is facing potential tariffs imposed by President Trump, which could significantly impact exports, particularly to the US. High export dependence and questionable quality standards underscore the need for reform and improved regulation to maintain the industry’s reputation and market position.